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Abstract.  Ribophorins I and II are type I transmem- 
brane glycoproteins of the ER that are segregated to 
the rough domains of this organelle.  Both ribophorins 
appear to be part of the translocation apparatus  for 
nascent polypeptides that is associated with membrane- 
bound ribosomes and participate in the formation of a 
proteinaceous network within the ER membrane that 
also includes other components of the translocation 
apparatus.  The ribophorins are both highly stable pro- 
teins that lack O-linked sugars but each contains one 
high mannose N-linked oligosaccharide that remains 
endo H  sensitive throughout their lifetimes. 
We have previously shown (Tsao, Y.  S.,  N.  E. 
Ivessa, M.  Adesnik,  D.  D.  Sabatini,  and G. Kreibich. 
1992. J.  Cell Biol. 116:57-67) that a COOH- 
terminally truncated variant of ribophorin I that con- 
tains only the first 332 amino acids of the luminal do- 
main (RI3a2), when synthesized in permanent transfor- 
mants of HeLa cells, undergoes a  rapid degradation 
with biphasic kinetics in the ER itself and in a  sec- 
ond, as yet unidentified nonlysosomal pre-Golgi com- 
partment.  We now show that in cells treated with 
brefeldin A  (BFA)  RI332 molecules undergo rapid 
O-glycosylation in a multistep process that involves the 
sequential addition of N-acetylgalactosamine,  galac- 
tose, and terminal  sialic acid residues.  Addition of 
O-linked sugars affected all newly synthesized RI332 
molecules and was completed soon after synthesis 
with a half time of about 10 rain.  In the same cells, 
intact ribophorins I and II also underwent O-linked 
glycosylation in the presence of BFA, but these mole- 
cules were modified only during a short time period 
immediately after their synthesis was completed, and 
the modification affected only a fraction of the newly 
synthesized polypeptides. More important,  these mole- 
cules synthesized before the addition of BFA were not 
modified by O-glycosylation. The same is true for 
ribophorin  I when overexpressed in HeLa cells al- 
though it is significantly less stable than the native 
polypeptide in control cells. We, therefore, conclude 
that soon after their synthesis,  ribophorins lose their 
susceptibility to the relocated Golgi enzymes that 
effect the O-glycosylation, most likely as a conse- 
quence of a conformational change in the ribophorins 
that occurs during their maturation,  although  it cannot 
be excluded that rapid integration of these molecules 
into a  supramolecular complex in the ER membrane 
leads to their inaccessibility to these enzymes. 
IBOPHORINS  I  and  II  are  two  well  characterized, 
highly stable ER resident glycoproteins  that have a 
type I (N, luminal;  C, cytoplasmic) transmembrane 
disposition and bear high mannose oligosaccharides  in their 
luminal segments (Rosenfeld et al., 1984; Harnik-Ort et al., 
1987; Crimaudo et al., 1987). These proteins are segregated 
to the rough domains  of the ER (Kreibich  et al.,  1978a, b; 
Macantonio et al.,  1984; Amar-Costesec et al.,  1984) and 
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appear to be part of the apparatus  that effects the transit)ca- 
tion of polypeptides synthesized  on membrane-bound ribo- 
somes across the ER membrane  (Yu et al.,  1989, 1990). 
Ribophorins and other components of the translocation  ap- 
paratus, such as the signal peptidase and the receptors for the 
signal recognition  particle and for the signal peptide itself, 
form a suprarnolecular  complex, or proteinaceous network, 
within the ER membrane that, after treatment  of rough mi- 
crosomes with neutral detergents,  can be recovered together 
with associated ribosomes in a rapidly sedimenting fraction 
(Kreibich  et al.,  1983;  Marcantonio  et al.,  1984;  Amar- 
Costesec et al., 1984; Wiedmann et al., 1987). The incorpo- 
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tion apparatus into this network may be responsible for the 
characteristic cisternal morphology of the rough portions of 
the ER, that is quite distinct from the tubular arrangement 
of membranes in the smooth portions of the organelle (Krei- 
bich et al., 1978a,b). Moreover, retention of  the components 
of the translocation apparatus in the ER may simply result 
from the fact that,  when assembled into the intramembra- 
nous network, they cannot gain access to the transport vesi- 
cles that normally flow from the ER to the Golgi apparatus. 
We have previously shown (Tsao et al., 1992) that a trun- 
cated variant of ribophorin I that contains only the first 332 
amino  acids  of the luminal  domain (RI332), when synthe- 
sized in permanent  transformants of HeLa cells, is rapidly 
degraded by a nonlysosomal pathway with biphasic kinetics. 
The first phase of degradation of RI332 begins immediately 
after synthesis is completed and takes place in the ER itself. 
The second  phase,  however, appears  to require  vesicular 
transport of the remaining molecules from the ER to a sec- 
ond compartment,  where degradation takes place at an ac- 
celerated rate. The two degradative compartments appear to 
fuse in cells treated with brefeldin A (BFA)  ~, in which the 
truncated ribophorin is degraded with monophasic kinetics 
at a rate intermediate between those of  the two normal degra- 
dative phases (Tsao et al., 1992). BFA is an antibiotic (H/irri 
et al., 1963) that profoundly affects the structure of  the Golgi 
apparatus and causes the backflow of Golgi enzymes to the 
ER (Fujiwara et al., 1988; Lippincott-Schwartz et al., 1989, 
1990; Doms et al., 1989; Ulmer and Palade, 1989). In this 
report we show that in the presence of BFA both the newly 
synthesized normal ribophorins  and the truncated ribopho- 
rin I variant undergo posttranslational  modifications which 
do not take place  in untreated cells.  Both ribophorins  un- 
dergo  O-glycosylation  and  the  N-linked  oligosaccharide 
chain in ribophorin II, but not that in ribophorin I, is con- 
verted into an endoglycosidase H (endo H) resistant form. 
However, whereas the truncated ribophorin I molecules re- 
main accessible to the relocated Golgi enzymes throughout 
their lifetime, the intact ribophorins I and II are susceptible 
to the modifying  enzymes only during or immediately after 
their synthesis. It would appear that only during this brief 
period the intact newly synthesized molecules are in a con- 
formational  state or location,  which, after BFA treatment, 
permits access to the relocated Golgi enzymes. Only during 
a subsequent maturation process do the intact ribophorins 
become  assembled  and  sequestered  in  a  supramolecular 
complex from which the truncated variant is excluded. 
Materials and Methods 
Reagents 
BFA was isolated in crystalline form from FL-24 fungi (Tamura et al., 
1968). A stock solution of BFA in methanol (5 mg/ml) was kept at -20~ 
Tunieamyr  was purehas~ from Calbiochem Corp. (La Jolla, CA), D-[1,6- 
3H]glucosamine  (52.7 Citmmole), D-[1-3H]galactose (21.7 Ci/mmole), and 
i>12-3H]mannose  (30 Ci/mmole) from New  England Nuclear Research 
Products (Boston, MA) and neuremmidase and nocodazole  from Sigma 
Chemical Co. (St. Louis, MO). The other glycosidases,  as well as lectins, 
1. Abbreviations used in this paper: BFA, brefeldin A; endo H, endogly- 
cosidase H; WGA, wheat germ agglutinin. 
were from Boehringer Mannheim Corp. (Indianapolis,  IN). The expression 
vector pMT2 was a gift from R. Kaufman (Genetics Institute, Boston, MA). 
Protein A-gold was obtained from Janssen Life Sciences Products (Beerse, 
Belgium),  LR white resin, medium grade,  from The London Resin Co., 
Ltd. (Hampshire, England) and anti-wheat germ agglutinin (WGA) and anti- 
Ricinus communis agglutinin (RCA) antibodies from E.Y. Laboratories, 
Inc., (San Mate.o, CA). 
Cell Culture and Transient Transfection 
The permanent HeLa cell transformant (HeLa-RI332) that expresses a trun- 
cated version of ribophorin I, consisting of the 332 NH2-terminal  amino 
acids of the luminal domain of this type I transmembrane  glycoprotein,  has 
been described (Tsao et al., 1992). Procedures for cell culture, radioactive 
labeling,  immunopreeipitation, endo H treatment, and PAGE, in either 8 
or 6-11% gradient gels, were also described previously (Tsao et al., 1992). 
In one experiment (see legend to Fig. 3) in which cells were labeled with 
tritium-labeled sugars  or  [~5S]methionine, methionine- and glucose-free 
MEM was used.  Before  use,  the tritium-labeled sugars  were dried in a 
SVCI00H Savant Speed Vac concentrator (Savant Instruments, Inc., Farm- 
ingdale,  NY) and dissolved  in medium to a concentration of 280 ~Cilml. 
Unless otherwise indicated, cultures treated with BFA were preincubated 
in methionine-free medium containing the drug for 30 rain before pulse 
labeling,  and the drug was present in the culture medium throughout the 
labeling and chase periods at a concentration of 5 ~g/ml. 
To overexpress ribophorin I the rat ribophorin I eDNA was excised from 
the pGEMI vector (Harnlk-Ort et al., 1987) and ligated into the eukaryofic 
expression vector pMT2 (Kaufman,  1990) using standard procedures (Sam- 
brook et al., 1989). HeLa cells were transiently transfected with this con- 
struct by the calcium phosphate precipitation method (10-20/zg DNA per 
100-ram dish) and the synthesis,  modification,  and stability of ribophorin 
I were analyzed at 50-75 h after transfection. 
Glycosidase Digestion 
Glycosidase treatment of immunoprecipitated proteins was carried out ac- 
cording to protocols provided by the suppliers.  Protein A-sepharose beads 
carrying the immunoprecipitates were boiled for 2 rain in a buffer contain- 
ing 0.3%  SDS and 100 mM Na-phosphate,  pH 6.5. The beads were then 
sedimented and the supernatanls containing the eluted protein diluted with 
the same volume  of a  NP-40 containing buffer to final concentrations of 
0.9% NP-40, 10 mM EDTA, 50 mM Na-phosphnte,  50 mM Na-acetate,  pH 
5.5, 20 U/ml trasylol.  Aliquots (50 ~d) were then treated for 24 h (or mock 
treated) with the following glycosidases before gel electrophoresis:  O-gly- 
cosidase (endo-N-acetyl-a-D-galactosaminidase  from Diplococcus pneu- 
moniae,  2.5 mU/sample), ~5-D-galactosidase (from bovine testes,  5 mU/ 
sample), endo-O-D-galactusidase  (from Bacteriodes frasilis  ,  5  mU/sam- 
pie), C~-L-fucosidase (from beef kidney, 5 mU/sample in a dilation buffer 
containing 100 mM Na-acetate,  pH 4.5, and no Na-phosphate), N-acetyl-O- 
D-glucosaminidase  (from  beef  kidney,  50 mU/sample) and neuraminidase 
(from  Clostridium  perfringens,  5 mU/sample). 
Electron Microscopy 
Subconlluent cultures of HeLa-RI332 cells were incubated with fresh media 
with or without 5/~g/rnl BFA at 370C for 2 h and fixed in 2% glutaral- 
dehyde in 0.1 M sodium cacodylate buffer, pH 7.4, for 45 vain on ice. The 
cells were then scrap~ off the dish, sedimented, postfixed with glutaralde- 
hyde and OsO4, and processed for routine EM. Thin sections were stained 
with uranyl acetate and lead citrate and examined in an electron micro= 
SCOpe operated at 80 kV (model  301; Philips Electronic Instruments Co., 
Mahwah,  NJ). 
Immunogold-Lectin Labeling of Ultrathin 
Frozen Sections 
Cultures of HeLa-RI332 cells were fixed first in the dishes with 2% parafor- 
maldehyde and 1% glutaraldehyde  in 0.1 M sodium phosphate buffer, pH 
7.4, and after scraping the cells were left in this fixative for a total of 2 h. 
Samples  were  stored overnight  in 0.1  M  sodium caeodylatr  buffer and 
processed for cryomicrotomy and immunolabeling, essentially as described 
by Tokuyasu  (1980)  with minor modifications  (Ivanov et al.,  1984;  De 
Lemos-Chiarandini et al.,  1987). Lectin labeling with WGA or RCA was 
carried out as described by Caiffiths et al. (1982), using anti-lectin antibod- 
ies and protein A-gold (5-ram-diameter).  Sections infused with LR White 
acrylic resin (Keller et al., 1984) were examined with a Philips 301 electron 
microscope operated at 60 kV. 
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Native and Truncated Ribophorin I Molecules 
Remain Endo H Sensitive in BFA-Treated Cells and 
their Posttranslational Modification Is Not Prevented 
by Tunicamycin Treatment 
We have previously shown (Tsao et al., 1992) that in perma- 
nently transfected HeLa cells expressing RI332, a truncated 
form of ribophorin I that lacks the membrane and cytoplas- 
mic segments and consists of only the amino-terminal 332 
amino acids of the luminal domain the truncated molecules 
are degraded with biphasic kinetics. Furthermore, in cells 
treated with BFA, the degradation of RI332 proceeded with 
monophasic kinetics and  a  rate constant intermediate be- 
tween the two rates observed in control cells (Tsao et al., 
1992). Upon careful analysis it was apparent that in contrast 
to control cells, in the presence of BFA the apparent molecu- 
Figure 1. The BFA-induced  modification of RI332 and ribophorin I 
does not affect its N-linked oligosaccharide, which remains endo 
H sensitive, and also occurs in cells treated with tunicamycin. (A) 
HeLa-RI332 cells were incubated in methionine-free medium for 
30 min, pulse labeled with [3SS]methionine  for 5 min, and chased 
for up to 2 h. BFA (5/zg/ml) was present during all these incuba- 
tions. Immunoprecipitates from samples taken at different times of 
chase were incubated with endo H or in the absence of the enzyme, 
as indicated, and analyzed by SDS-PAGE  followed  by fluorography. 
R/%z indicates the  position of the polypeptide generated from 
RI332 after removal of the N-linked oligosaccharide by endo H. 
The asterisks alongside lane a and on the band in lane f mark the 
position of RI'332.~, the polypeptide generated by endo H diges- 
tion of RI332.m. The position of the latter is marked with dots in 
lane e  and  alongside lane a.  (B)  HeLa-RI332 cells  were prein- 
cubated with tunicamycin (5 tzg/ml) for 1.5 h and in methionine-free 
medium containing tunicamycin and BFA (5 ~g/ml) for 30 min. 
They were then pulse labeled with [35S]methionine  for 5 min, and 
chased for up to 90 min in the presence of both drugs (c'-g'). Con- 
trol cultures, not treated with the drugs, were harvested immedi- 
ately  after the  pulse  (a'),  or  after  90  min  of chase  (b').  Im- 
munoprecipitates  were  obtained  and  analyzed  by  SDS-PAGE, 
followed by fluorography. (m), A modified form of the ribophorin 
I and RI332 polypeptides observed in the presence of BFA; (*) a 
form lacking the N-linked oligosaccharide. 
lar  weight  of  the  labeled  RI332 molecules  underwent  a 
progressive increase throughout the chase (Fig.  1 A, lanes 
a, c, e, g, i, k, and m). After 10 min of chase •50%  of the 
RI332 molecules are modified (lane c), and after 30 min, the 
posttranslational modification is essentially completed (lane 
g).  After prolonged chase periods, the decaying pool con- 
tained a heterogenous population of RI332 molecules, repre- 
sented by several closely spaced electrophoretic bands (Fig. 
1 A, lanes k and m). 
Both ribophorin I and its truncated variant (RI332) contain 
a  single N-linked high-mannose oligosaccharide chain at- 
tached to Asn27s, which can be cleaved off by endo H diges- 
tion (Rosenfeld et al.,  1984; Harnik-Ort et al.,  1987;  Tsao 
et al.,  1992). To determine whether the apparent increase in 
the molecular masses of the truncated ribophorin I  mole- 
cules that appear in BFA-treated cells reflects a processing 
of the N-linked oligosaccharide chain, the effect of endo H 
treatment on this protein was examined. As is shown in Fig. 
1 A, endo H digestion increased the electrophoretic mobility 
of all the labeled truncated ribophorin I molecules produced 
in BFA-treated cells. The same behavior was found for intact 
ribophorin I (not shown). This demonstrates that the N-linked 
oligosaccharide chains in these molecules had not undergone 
the trimming and addition of sugars that have been observed 
for other proteins  as  a  consequence of the  BFA-induced 
backflow of Golgi enzymes to the ER (Lippincott-Schwartz, 
1989; Doms et al., 1989). However, the deglycosylated trun- 
cated products were still of higher molecular weight than 
those produced by endo H digestion of the labeled molecules 
present immediately after the pulse, which had not yet un- 
dergone the BFA-induced posttranslational modification (Fig. 
1 A,  compare R/%2.m and R/%2).  This demonstrates that 
the latter modification affects parts of the ribophorin I mole- 
cule other than the N-linked oligosaccharide chain. 
That the BFA-induced modification of ribophorin I does 
not involve, or even require, the presence of the N-linked 
oligosaccharide  chain  was  definitively established  by  the 
finding (Fig.  1 B) that BFA treatment led to a decrease in 
the electrophoretic mobility of both the normal full length 
and the truncated (RI332) molecules, even when these were 
synthesized in the presence of tunicamycin, a drug that pre- 
vents  the  addition  of N-linked  oligosaccharide  chains  to 
newly  synthesized polypeptides  (Takatsuki  et  al.,  1975). 
Moreover, in this experiment it is apparent that the endoge- 
nous intact ribophorin I molecules also undergo a similar de- 
crease in electrophoretic mobility although only a  fraction 
(<50%) of the population of the newly synthesized native 
ribophorin I molecules was eventually modified (Fig.  1 B, 
R/*m). The possibility that in BFA-treated cells the ribopho- 
rin molecules were modified by the addition of phosphate or 
sulfate groups was eliminated by the finding that prolonged 
incubation with medium containing radioactive phosphate 
(Capasso et al.,  1989) or sulfate (Hutmer, 1988) did not re- 
sult in detectable labeling of either the intact or truncated 
ribophorin I molecules (results not shown). We therefore ex- 
amined the possibility that the modified ribophorins had ac- 
quired O-linked oligosaccharides, which are normally not 
present in these molecules. 
Modified Ribophorin I Molecules 
Present in BFA-treated Cells Contain 
O-linked Oligosaccharides 
First, the effect of various glycosidases that do not affect the 
Ivessa et al. Brefeldin A-induced O-Glycosylation of Ribophorins  951 core  sugars  of  N-linked  oligosaccharides,  on  the  elec- 
trophoretic mobility of the modified ribophorins was inves- 
tigated (Fig. 2). Digestions with these enzymes were carded 
out after different times of chase, since O-linked chains grow 
by  sequential  addition  of monosaccharide  units  (Sadler, 
1984),  which  progressively  alters  their  susceptibility  to 
cleavage by specific enzymes. After 30 min of chase, only 
endo-/3-galactosidase (Fig.  2,  lane e),  but neither  O-gly- 
cosidase, which removes O-linked oligosaccharides with ter- 
minal galactose residues (Umemoto et al.,  1977),  nor the 
exoenzyme/3-galactosidase (Fig. 2, lane d) substantially in- 
creased the electrophoretic mobility of the modified RI3a2 
molecules.  The  apparent  molecular mass  of the  endo-/3- 
galactosidase-treated molecules was, however,  still higher 
than that of the protein synthesized in control cells (Fig. 2, 
compare lane e with lanes a and h). It appears, therefore, that 
the modified molecules contain O-linked oligosaccharides 
with internal galactose residues. Neuraminldase, an enzyme 
that cleaves off terminal sialic acid residues, already had a 
detectable effect on molecules obtained after 30 min of chase 
(Fig. 2, lane  f) and, when applied to samples chased for 90 
min, it completely eliminated the slower migrating compo- 
nents of the modified ribophorin population, corresponding 
to the diffuse upper portion of the RI332,m band in Fig.  2 
(compare lanes i and k).  It is noteworthy that, even after 
removal of the terminal sialic acid residues by neuraminldase, 
the oligosaccharide chains remained resistant to O-glycosi- 
dase (Fig. 2, compare lanes k and l). These data indicate that 
the galactose residues in the chains are still covered by other 
distal sugars. 
The RI332 molecules contain sugars that are not part of 
N-linked oligosaccharides could be directly demonstrated in 
BFA-treated cells that had been preincubated with tunicamy- 
cin to suppress N-glycosylation. In these experiments (Fig. 
3), the cells were incubated for 90 min in media containing 
either [3H]glucosamine  (a metabolic precursor of N-acetyl 
galactosamine),  [3H]galactose,  or  [3H]mannose,  the latter 
serving  as  a  control  to  verify  the  effectiveness  of  the 
tunicamycin inhibition of N-glycosylation. In a parallel cul- 
ture,  cells  were  labeled under  the  same  conditions with 
[35S]methionlne during a 90-min incubation period to dis- 
play the full range of RI332 molecules at various stages of 
modification. Fig. 3 (lane a) shows that these molecules en- 
compass  the molecular mass  range of 40-44  kD,  and  it 
seems  likely that the  fastest migrating component corre- 
sponds to the totally unglycosylated  polypeptide. In contrast 
to the situation with [35S]methionlne, sugar precursors were 
only incorporated into the slower migrating forms of trun- 
cated ribophorin molecules that are characteristic of BFA- 
treated cells (Fig.  3, lanes b and c). The two most slowly 
migrating  species  of RI332 were  labeled  with  [3H]glucos- 
amine,  but  only  the  slower  of these  was  labeled  with 
[3H]galactose.  This labeling pattern would be expected if 
N-acetylgalactosamine, derived from  [3H]glucosamine,  is 
attached directly in an O-glycosidic bond to serine or threo- 
nine residues and galactose residues are subsequently added 
(Sadler,  1984).  In cells incubated with [3H]mannose,  only 
trace amounts of radioactivity were incorporated into RI332 
molecules and this occurred in the modified molecules of 
lowest electrophoretic mobility. Given the fact that nine man- 
nose residues are present in the core of N-linked oligosac- 
charides CKornfeld and Kornfeld, 1985), this very low incor- 
poration  of  [3H]mannose  probably  reflects  a  very  low 
residual level of  N-glycosylation  in the presence of  tunicamy- 
cin,  or a  very low degree of conversion of [3H]mannose 
into other labeled sugars. 
It is striking that in BFA-treated cells incubated for 90 min 
with the sugar precursors,  incorporation into the endoge- 
nous intact ribophorin I molecules was undetectable (Fig. 3, 
lanes b to d), despite the fact that the amount of native pro- 
tein in these cells, as measured by immunoblotting, is much 
higher than that of truncated molecules (not shown). Since 
pulse-labeling  experiments  with  [35S]methionlne  in  BFA- 
treated cells (Fig. 1) showed that a substantial proportion of 
the newly synthesized intact ribophorin I molecules is modi- 
fied during the subsequent chase, the lack of detectable in- 
corporation of radioactive sugars into intact ribophorin I in- 
dicates  that only newly  synthesized,  and  not preexisting 
ribophorin molecules, can serve as a substrate for the O-gly- 
cosylation system. Since ribophorin I is synthesized at an 
approximately 25-fold lower rate than RI332, the O-glyco- 
sylated forms of the newly made ribophorin I molecules may 
not be easily detectable by labeling with tritiated sugars. 
Figure  2.  O-linked oligosaccharides partially sensitive to endo- 
~-v-galactosidase and neuraminidase are linked to R.~332 in cells 
treated with BFA. BFA (5 #g/nil) treated HeLa-RI332  cells (lanes 
b-f and h-l)  were pulse labeled with [35S]methionine for 5 min 
and chased for 30 or 90 min as indicated. Control cultures (lanes 
a and g) were incubated in methionine-free  medium, labeled, and 
chased in the absence of BFA. Immunoprecipitates obtained from 
cell lysates were incubated for 24 h with (lanes c-f, j-l) or without 
(lanes a,  b,  and  g-i)  the following glycosidases: O-glycosidase 
(endo-N-acetyl-a-v-galactosaminidase,  enzyme 1); ~-D-galactosi- 
dase (enzyme 2); endo-/3-D-galactosidase (enzyme 3); and neur- 
aminidase (enzyme 4).  After incubation, the samples were ana- 
lyzed by SDS-PAGE, followed by fluorography. 
Figure 3. Incorporation of la- 
beled sugars  into O-linked  oli- 
gosaccharides of RI332 in BFA- 
treated cells. HeLa-RI332  cells 
preincubated in complete me- 
dium with tunicamycin  (5 #g/ 
ml) for 2 h were then incubated 
for  30  rain in  glucose- and 
methionine-fre~  medium con- 
taining  both tunicamycin  (5 #g/ 
ml) and BFA (5 #g/ml), before 
labeling for 90 min with [3sS]- 
methionine  (a),  [I,6-3H]-D  - 
glucosamine (b), [l-3H]-D-galactose  (e), or [2-3H]-D-mannose (d), 
in the presence of both drugs. Immunoprecipitates obtained from 
cell lysates were analyzed by SDS-PAGE and fluorography  (3  mo 
exposure). 
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of  O-linked Sugars to Ribophorin H Molecules 
as well as to the Modification of  their 
N-linked Oligosaccharides 
The behavior of ribophorin II, a resident glycoprotein of the 
ER membrane with the same transmembrane disposition as 
ribophorin I (Crimaudo et al.,  1987;  Pirozzi et al.,  1991), 
was also examined in BFA-treated cells. It must first be noted 
that in control HeLa cells only "~50% of the newly synthe- 
sized ribophorin II molecules acquire an N-linked oligosac- 
charide chain (Fig. 4, RI] vs RII* lane a) and are therefore 
sensitive to endo H treatment (lane b). A pulse-chase experi- 
ment demonstrates that in BFA-treated cells both types of 
ribophorin II molecules (that is, those that bear [RII], as well 
as those that lack [RH*] N-linked oligosaccharides) are con- 
vetted to more slowly migrating forms. Moreover, in con- 
trast to the situation with ribophorin I,  after a  2-h chase 
period,  the  modified  molecules  were  almost  completely 
resistant to endo H digestion (Fig. 4, compare lanes e and 
f). This indicates that the high mannose N-linked oligosac- 
charities in ribophorin II were processed by the relocated 
Golgi enzymes, and that O-linked sugars were added to the 
ribophorin II polypeptides, whether or not they contain an 
N-linked oligosaccharide. The addition of  O-linked sugars to 
ribophorin  II  in  BFA-treated  cells  was  confirmed by  the 
finding that the drug led to the appearance of more slowly 
migrating forms even in cells that were treated with tunica- 
Figure  4. In BFA-treated  cells, the N-linked oligosaccharide of  ribo- 
phorin II becomes endo H resistant and O-linked sugars are added 
to the polypeptide backbone. HeLa cells were labeled for 1 h with 
[3~S]methionine with (lanes c-f and h) or without (a, b, and g) 
addition of BFA (5 tzg/ml) 30 rain before labeling. One BFA-treated 
sample (e and f) was incubated in chase medium containing BFA 
for 2 h. After lysis and immunoprecipitation with anti-ribophorin 
II antibody the samples were divided into two equal aliquots that 
were either mock treated (a, c, and e) or treated with endo H (b, 
d, and  f) and then analyzed by SDS-PAGE and fluorography. HeLa 
cell cultures were also pretreated with tunicamycin (5/~g/ml) for 
2 h and one culture was treated with BFA (5/~g/ml) for 30 min be- 
fore labeling for 1 h with [35S]methionine. RII* is the membrane- 
inserted but completely unglycosylated ribophorin II polypeptide 
that, to some degree, is always found in control cells, but it is the 
only form present in cells treated with tunicamycin in the absence 
of BFA. R/I is the ribophorin II molecule containing a high man- 
nose (endo H sensitive) N-linked oligosaccharide chain, which is 
found normally in the ER membrane. R/Ira and R/Fro are O-glyco- 
sylated forms found in BFA-treated  cells that are derived from RII 
and RII'. In the presence of BFA the N-linked oligosaccharide in 
RII and in its O-glycosylated derivative (R/1,) is converted into an 
endo H resistant form. 
mycin to suppress N-glycosylation (Fig. 4, lanes g  and h). 
In this case, also in contrast to the situation with ribophorin 
I,  two distinct modified forms of ribophorin II were pro- 
duced, which most likely correspond to molecules contain- 
ing different numbers of O-linked oligosaccharide chains. 
Preexisting Golgi Enzymes Effect the Posttranslational 
Modification of  RI3n in BFA-treated Cells 
The presence of galactose and  sialic acid residues  in the 
modified ribophorin I  molecules indicates that after BFA 
treatment the respective glycosyltransferases, which are nor- 
maUy present only in the trans-cisternae of  the Golgi appara- 
tus (Kornfeld and Kornfeld, 1985; Cummings et al.,  1983; 
Elhammer and Kornfeld, 1984), are found in the ER. This 
could result either from a relocation of preexisting Golgi en- 
zymes, as has been demonstrated for o~-mannosidase  H and 
galactosyltransferase  (Lippincott-Schwartz  et  al.,  1989, 
1990),  or  from  the  accumulation  of  newly  synthesized 
glycosyltransferases that fail to leave the ER in the presence 
of the drug.  To distinguish between these possibilities, the 
effect of BFA was assessed in cells that, after pulse labeling 
with psS]methionine, were incubated with the protein syn- 
thesis inhibitor cycloheximide for 30 min, a period sufficient 
to allow the egress from the ER of newly synthesized pro- 
teins destined to the Golgi apparatus.  As shown in Fig.  5, 
even under these conditions, BFA treatment resulted in the 
appearance  of the  more  slowly migrating  forms  of RI332 
with the same kinetics as in the absence of cycloheximide. 
It therefore can be concluded that the modifications induced 
by BFA are carried out by preexisting glycosyltransferases, 
relocated from the Golgi apparatus to the ER as a result of 
treatment with the drug. It may also be noted in Fig. 5 that 
treatment with cycloheximide appeared to slow down the 
degradation of RI332 molecules. 
BFA Treatment Causes a Redistribution of  lz,  ctin 
Binding Sites Characteristic of Trans-Golgi Cisternae 
into the ER 
The appearance of trans-Golgi components in the ER as a 
result of BFA treatment could also be demonstrated by EM 
using lectin labeling techniques and immunogold detection 
procedures on  ultrathin  frozen sections  (Gdfliths  et  al., 
1982). In agreement with previous reports (Fujiwara et al., 
Figure 5. The posttranslational modification of RI332 observed in 
BFA-treated cells is etfeeted by pre-existing enzyme.s. Cultures of 
HeLa-RI332 cells were pulse labeled with [~S]methionine for 10 
min and, after this time, two cultures were placed on ice (lanes a 
and n). The other cultures were incubated for 30 rain in complete 
chase medium with (h-m) or without (b-g) cyclobeximide (10 #g/ 
ml). After the chase, BFA (5/~g/ml) was added and the incubation 
continued for  up to 120 min. At the chase times indicated, the cells 
were lysed with an SDS-containing buffer and processed for immu- 
noprecipiation and SDS-PAGE, followed by fluorography. 
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Palade, 1989), BFA led to profound changes in the structure 
of the Golgi apparatus which, after treatment with the drug, 
was apparently reduced to clusters of vesicular and tubular 
elements located near partly rough and partly smooth ER 
cistemae with the typical appearance of transitional elements 
(Jamieson and  Palade,  1967).  As  expected from previous 
studies (Tartakoff  and Vassalli, 1983), in control HeLa cells, 
Figure 6. BFA treatment of HeLa cells leads to the appearance of WGA binding sites in the ER and nuclear envelope. Ultrathin frozen 
sections from control HeLa-RI332  cells (A), or cells treated with BFA (5 t~g/rnl) for 5 min (B), or 2 h (C and D) were incubated with 
WGA. The sites of lectin binding were detectexl using anti-WGA antibodies and protein A-gold. In control cells (A), the nuclear envelope 
(NE) and ER are not labeled,  but dense  labeling is observed in trans-Golgi  cisternae  (GA) and the plasma membrane  (PM). Within 
5 mitt after BFA treatment  (B), some WGA binding is observed in the nuclear envelope and ER, as well as in profiles corresponding to 
remnants of the Golgi apparatus  (/arge arrows). After 2 h of BFA treatment,  the ER and NE are much more intensely labeled. 
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glucosamine residues (Bhavanandan and Katlic, 1979),  la- 
beled intensely the trans-cisternae of the Golgi apparatus, 
but not the membranes or luminal content of the ER (Fig. 
6 A). On the other hand, in cells treated with BFA (5/~g/ml) 
for times as short as 5 min (Fig. 6 B) and up to 2 h  (Fig. 
6  C), WGA binding situs  were present throughout the ER 
and in the nuclear envelope, as well as in the apparent rem- 
nants of the Golgi apparatus (Fig. 6 D). Similar results were 
obtained with the lectin RCA,  which recognizes terminal 
galactose residues (Baenziger and Fiete, 1979), or when the 
cells were treated with cycloheximide  for 1 h before the addi- 
tion of BFA to deplete the Eli of newly synthesized Golgi 
proteins (results not shown). These findings are in accord 
with the preceding biochemical demonstration that BFA in- 
duces a  redistribution of O-glycosylating enzymes of the 
trans-region of the Golgi apparatus, such as galactosyl- and 
sialyltransferases, into the ER. 
Soon after Their Synthesis, Intact Ribophorin 
Molecules Become Inaccessible to the O-Glycosylating 
Golgi Enzymes Relocated to the ER 
As shown above, all the truncated ribophorin I  molecules 
(RI332) synthesized during a brief (5 rnin) pulse eventually 
become posttranslationally modified (Fig. 1) during a chase 
period in the presence of BFA, even when the drug was 
added 30 rain after labeling (Fig.  5).  On the other hand, 
<50% of the intact ribophorin molecules synthesized during 
a brief pulse undergo the posttranslational modification (Fig. 
1 B). Moreover, in cells incubated with labeled monosaccha- 
rides (Fig. 3), O-glycosylation of previously synthesized in- 
tact ribophorin I molecules does not appear to take place to 
any significant extent. This suggests that ribophorin I mole- 
cules  are  susceptible  to  O-glycosylation only  during  a 
limited period after their synthesis. It seems likely that this 
could correspond to the time required for the newly synthe- 
sized  polypeptides  to  undergo  a  conformational change 
and/or eventually to become incorporated into the protein- 
aceous network in the RER where the mature protein has 
been shown to be contained (Kreibich et al., 1978a,b; Yu et 
al.,  1989). 
To estimate the time interval during which the newly syn- 
thesized ribophorin I molecules are accessible to the O-gly- 
cosylation system, HeLa cells were labeled for  1 h  in the 
presence or absence of BFA, and the extent to which the 
posttranslational  modification  occurred  in  a  subsequent 
chase period in the presence of the drug was assessed. After 
this relatively long labeling period, which facilitates the de- 
tection of the labeled ribophorin I molecules, modified full 
length polypeptides were detected only in cells labeled in the 
presence of the drug (Fig. 7 A). The failure of BFA to cause 
the modification  of  previously labeled ribophorin molecules, 
however, could result in part from the time required for the 
drug to exert its effect and the Golgi enzymes to reach the 
ER. The latter has recently been estimated to be considera- 
bly less than 15 min (Donaldson et al.,  1991), which is in 
accordance with our observations of the appearance of lectin 
binding sites in the ER within 5 rain of BFA treatment (Fig. 
6 B). Since ribophorin I is a stable protein that can only be 
weakly labeled during a short pulse, it is difficult to carry 
out this type of experiment with a shorter labeling period, 
to obtain accurate kinetics for the modification of the intact 
Figure 7. In BFA-treated  cells, intact ribophorin I and ribophorin II 
molecules can be posttranslationally glycosylated only during a 
limited period after their synthesis. HeLa cells (A and C) and HeLa 
cells transiently overexpressing  ribophorin I (B) were preincubated 
in methionine-free  medium for 30 min with (lanes a-c), or without 
(d-g) BFA (5 t~g/ml)  and then labeled with [~SS]methionine  for 1 h 
in the presence (a-c) or absence (d-g) of the drug. Some  cultures 
(a, d, and g) were placed on ice immediately after the labeling pe- 
riod, whereas the others were incubated in chase medium contain- 
ing BFA for 2 h (b and e) or 4 h (c and f). Immunoprecipitates  ob- 
tained from cell lysates with antibodies against ribophorin I (A and 
B) or ribophorin II (C) were analyzed by SDS-PAGE, followed  by 
fluorography.  The labeled  bands are marked using the abbreviations 
introduced in the legends to Figs. 1 and 4. 
molecule. If we assume that, when available to the modify- 
ing  enzymes,  the  intact  and  truncated  molecules  are 
modified with the same kinetics, it can be concluded that 
within  15  rain or less after their synthesis is completed, 
ribophorin I molecules are no longer susceptible to mod- 
ification by the relocated Golgi enzymes. 
A similar experiment to examine the behavior of ribopho- 
tin II (Fig. 7 C) showed that, like ribophorin I, only when 
the  BFA  treatment was initiated before the pulse did the 
newly synthesized (labeled) ribophorin II molecules undergo 
the  modifications carried  out by the  relocated  Golgi en- 
zymes. Therefore, both ribophorins are susceptible to the ac- 
tion of these enzymes only during a limited time period after 
their synthesis. 
If the ribophorins rapidly became resistant to the action 
of the Golgi glycosyltransferases as a consequence of their 
incorporation into an oligomeric assembly, one would ex- 
pect that overexpression of one of these proteins, so that its 
levels far exceeded those of other components of the assem- 
bly, would lead to much more efficient O-glycosylation. Sur- 
prisingly, when the full-length ribophorin I was transiently 
overexpressed  in  HeLa cells  no  O-glycosylation was  ob- 
served when BFA treatment was initiated after completion of 
ribophorin I synthesis (Fig. 7 B, lanes d-f).  Furthermore, 
the level of O-glycosylation of ribophorin I observed when 
synthesis occurred in the presence of BFA did not markedly 
change (Fig. 7 B, lanes a-c) when compared with that seen 
in control cells ~ig. 7 A, lanes a-c). This result suggests that 
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complex, undergoes a conformational change that renders it 
resistant to O-glycosylation in BFA-treated  cells. 
It has previously been observed that ribophorin I is a long- 
lived protein of the RER (Rosenfeld et al.,  1984;  see also 
Fig.  8 A).  A  comparison of the degradation rate of ribo- 
phorin I in transfected cells to that in control cells revealed 
that the overexpressed molecules were much more unstable 
(Fig.  8 B).  Since after 24 h of chase approximately equal 
amounts of labeled ribophorin I remained in transfected and 
control cells, it would appear that the overexpressed mole- 
cules turnover with a half-life of 8 h  or less.  It should be 
noted that in these transient transfection experiments only 
~5 % of the cells express the foreign protein, so that in the 
expressing cells, ribophorin I is being synthesized at up to 
50  times the control levels.  This finding that the overex- 
pressed portion of the ribophorin I molecules is degraded 
significantly faster than the endogenously expressed poly- 
peptide is consistent with the notion that the high stability 
of endogenous ribophorin I results from its integration into 
an oligomeric assembly. 
Discussion 
Ribophorins I and II, as well as other components of the 
translocation apparatus, appear to represent a class of resi- 
dent ER membrane proteins, that, in contrast with other well 
studied ER polypeptides, such as the El9 protein of adenovi- 
rus  (P~bo  et al.,  1987; Nilsson et al.,  1989) and UDP- 
glucuronosyltransferase (Jackson et al.,  1990),  do not con- 
tain retention signals at their extreme COOH-termini (Jack- 
son et al.,  1990).  Ribophorins form large macromolecular 
assemblies or complexes within the ER membrane (Kreibich 
et al., 1978a,b; Yu et al., 1989) and it seems likely that their 
retention in the ER simply results from the fact that, once 
incorporated into these complexes, they cannot gain access 
to the vesicles that mediate the transport to the Golgi appara- 
tus of other proteins synthesized in the ER. Thus, the segre- 
gation of proteins  that  form large  macromolecular com- 
plexes, although resulting from a true retention mechanism, 
would not require a signal common to all of them. Instead, 
the retention of each protein might only involve its interac- 
tion with another specific component of the macromolecular 
assembly. 
That a true retention mechanism, rather than a mechanism 
involving retrieval from the Golgi apparatus, is responsible 
for the segregation of many proteins in the ER, including the 
ribophorins, was first suggested by the finding that N-linked 
oligosaccharide chains in ER proteins do not undergo con- 
version to complex forms, which are resistant to endo H and 
are capable of binding the lectins WGA and RCA, a process 
that requires the action of enzymes located in the Golgi ap- 
paratus (Rodriguez-Boulan et al., 1987a,b;  Rosenfeld et al., 
1984; Brands et al., 1985; Yamamoto et al., 1985).  The va- 
lidity of this argument for any particular protein, however, 
rests on the premise that the protein could serve as a sub- 
strate for the Golgi enzymes, were it to become accessible 
to them. In the current work this is demonstrated for N-gly- 
cosylated ribophorin II molecules, which normally remain 
sensitive to endo H but in BFA-treated cells become resistant 
to digestion with this enzyme. A  similar behavior was re- 
cently observed  for  ERp99,  another ER  resident protein 
Figure 8. Ribophorin I when overexpressed in HeLa ceils becomes 
unstable. HeLa ceils (A) and HeLa cells transiently overexpressing 
ribophorin I (B) were incubated in methionine-free  medium for 30 
min, pulse labeled with [3SS]methionine  for 1 h, and chased for up 
to 24 h. At the chase times indicated, the cells were lysed with an 
SDS-containing buffer and processed for immunoprecipitation  and 
SDS-PAGE, followed by fluorography. 
(Lippincott-Schwartz  et  al.,  1989).  In  this  regard,  our 
finding that in BFA-treated  cells the N-linked oligosaccha- 
ride chain in ribophorin I remained endo H sensitive clearly 
demonstrates that access to the enzymes that could effect its 
conversion to the endo H resistant form is not sufficient to 
ensure that the modification takes place. Indeed, the confor- 
mation of  glycoproteins may very well determine the suscep- 
tibility of their sugar chains to the action of the relocated 
modifying enzymes. In addition, it can not be excluded that 
the single N-linked oligosaccharide chain of ribophorin I 
would acquire resistance to digestion with endo H, if the 
molecule would pass through the Golgi stacks in an ordered 
fashion, instead of being exposed to the Golgi glycosyltrans- 
ferases in the BFA-induced ER-Golgi hybrid compartment. 
In fact, we have observed (unpublished observations) that the 
five N-linked oligosaccharide chains of the hemagghtinin of 
influenza, which normally are converted into endo H resis- 
tant forms during passage of the protein through the Golgi 
apparatus,  are  not modified by  relocated Golgi  enzymes 
when the protein remains in the ER in BFA-treated cells. 
We also found that both ribophorins, which normally do 
not acquire O-linked oligosaccharides, do so after BFA treat- 
ment. This demonstrates that they, indeed, can serve as sub- 
strates for the enzymes that carry out this modification, and 
therefore, in the absence of the drug must not be exposed to 
them. O-glycosylation involves  the addition of N-acetylga- 
lactosamine to serine and threonine residues in the polypep- 
tide backbone,  followed by linkage to galactose and sialic 
acid (Sadier,  1984).  The exact subcellular location of the 
N-acetyl galactosaminyl transferase that initiates growth of 
the O-linked oligosaccharide chain has not been established, 
although the relatively rapid kinetics with which this mod- 
ification takes place (Tooze et al., 1988),  as well as the fact 
that certain mutant low density lipoprotein (LDL) receptors 
that fail to transverse the Golgi apparatus nevertheless ac- 
quire O-linked sugars  (Cummings et al.,  1983),  has sug- 
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partment. In fact, a recent study of the E1 glycoprotein of 
the mouse hepatitis coronavirus virus MHV-A59  (Tooze et 
al., 1988) concluded that addition of  N-acetylgalactosamine 
to this protein occurs in a pre-Golgi compartment, which is 
also the site of budding of the virion into the lumen of the 
endomembrane system and morphologically resembles tran- 
sitional elements and vesicles found between the ER and the 
Golgi apparatus. Since ribophorins I and II, as well as the 
truncated ribophorin I variant, RI332, undergo O-glycosyla- 
tion only in BFA-treated  cells, we can conclude that under 
normal circumstances these molecules do not even reach this 
intermediate compartment, which may be the same as the 
"salvage  ~ compartment from where KDEL-containing lumi- 
nal proteins that escape from the ER are retrieved to this or- 
ganelle (Pelham, 1989).  This reinforces the conclusion that 
the segregation of ribophorins I and II does not involve a re- 
trieval mechanism. It should be noted that if, indeed, O-gly- 
cosylation takes place  in the "salvage  " compartment, one 
would expect that some luminal ER proteins that recycle 
through this compartment would contain O-linked sugars, a 
prediction that can be tested experimentally. 
Our  observations  that  in  BFA-treated  ceils  galactose 
residues are  incorporated into the truncated ribophorin I 
variant and that neuraminidase treatment increases the elec- 
trophoretic  mobility of this protein,  provide biochemical 
evidence  that  oligosaccharide-modifying enzymes  of the 
trans-region of the Golgi apparatus become relocated to the 
ER after BFA treatment. The presence of a galactosyltrans- 
ferase in the ER of BFA-treated cells was previously demon- 
strated immunocytochemically (Lippincott-Schwartz et al., 
1990),  as well as by the finding that mannose-6-phosphate 
receptor molecules synthesized in the presence of the drug 
bind to RCA-I lectin columns (Chege and Pfeffer, 1990). The 
sialic acid residue(s) that are present in the truncated ribo- 
phorin I and are removed by neuraminidase must be part of 
O-linked  oligosaccharide  chain(s),  since  the  protein  re- 
mained endo H sensitive and, therefore, its single N-linked 
oligosaccharide did not contain sialic acid. 
The striking relocation of Golgi components caused by 
BFA was also manifested by the appearance of binding sites 
for the lectins RCA-I and WGA in the ER. The former lectin 
binds to exposed galactose residues (Baenziger and Fiete, 
1979)  and the latter to exposed N-acetyl glucosamine and 
sialic acid residues (Bhavanandan and Katlic, 1979).  As ex- 
pected from previous studies with myeloma cells (Tartakoff 
and Vassalli,  1983),  we found that in control HeLa cells in- 
tracellular binding sites for both lectins were almost exclu- 
sively present in the trans-region  of the Golgi apparatus and 
not to any significant extent in the ER or nuclear envelope. 
After BFA treatment, however, even in cells in which protein 
synthesis was inhibited with cycloheximide, both lectins in- 
tensely labeled the ER and the nuclear envelope. These elec- 
tron microscopic results are in marked contrast with im- 
munofluorescence observations by  Lippincott-Schwartz et 
al.  (1989)  of cultured normal rat kidney (NRK) cells,  in 
which BFA treatment did not lead to a relocation of WGA 
binding sites. In later work these authors observed that BFA 
caused the complete relocation to the ER of the trans-Golgi 
enzyme galactosyltransferase and, therefore, suggested that 
WGA binding sites are not relocated because they are pre- 
dominantly localized in the trans-Golgi network (Lippincott- 
Schwartz et al., 1990). This may indeed be the case in NRK 
cells, but it is also possible that the lectin binding sites that 
appear in the ER after BFA treatment do not all correspond 
to  redistributed  previously  existing  Golgi  glycoproteins. 
Rather,  to  an extent which may vary with the cell type, 
such sites may be created by a  sialyltransferase relocated 
from the medial or trans-Golgi region, operating on ER resi- 
dent proteins, as well as on relocated cis- and medial Golgi 
proteins. In considering the location of lectin binding sites 
within the Golgi apparatus, one must note that an integral 
membrane protein confined to cis- and medial Golgi cister- 
nae has been identified that contains sialic acid residues on 
both its N-linked and O-linked oligosaccharide chains (Yuan 
et al., 1987). This led to the alternative suggestions that this 
protein is either modified in the trans-Golgi network and 
then returned to the more proximal region of the Golgi ap- 
paratus, or that an as yet uncharacterized sialyltransferase is 
located in cis- and medial cisternae. 
A  striking observation in this  study was that,  in BFA- 
treated cells, newly synthesized, but not preexisting intact 
ribophorin I molecules, were susceptible to O-glycosylation 
by the relocated Golgi enzymes. As a consequence, only a 
very small fraction of the total cell complement of endoge- 
nous  ribophorins  acquired  the  modification.  The  intact 
ribophorin molecules that received the modification (<50 % 
of  those that were labeled during a 5-min pulse) did so during 
a  brief period  after  their  synthesis.  In  addition,  overex- 
pressed full-length ribophorin I molecules, synthesized in 
excess of the  stoichiometric amounts present  in untrans- 
fected cells, were also susceptible to O-glycosylation for a 
limited period after their synthesis. On the other hand, the 
truncated ribophorin molecules were suspectible to O-gly- 
cosylation throughout their lifetime and were quantitatively 
modified during the first 30-rain period after the addition of 
BFA. It seems likely that this difference between the intact 
and the truncated ribophorins results from a conformational 
change that only the intact polypeptide molecules undergo 
soon after their synthesis, and possibly also from their se- 
questration in the supramolecular assembly of the ER mem- 
brane that is responsible for their retention within the or- 
ganelle.  The  relatively  rapid  degradation  of  full-length 
ribophorin molecules expressed at levels above the stoichio- 
metric amounts of other components of the supramolecular 
assembly in the RER membrane is likely to be a  conse- 
quence of  their failure to be assembled normally. This would 
be analogous to the rapid turnover of other monomeric com- 
ponents of multimeric proteins that is observed when in- 
dividual subunits are synthesized in excess (Bonifacino and 
Lippincott-Schwartz, 1991). 
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